The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth

SIMPLE SUMMARY: The low survival rate of osteosarcoma (OS) patients underlines the urgency of developing new therapeutic strategies for this disease. In recent years, the important role of Hippo/YAP signaling in cancer has been evaluated, focusing on the possibility of targeting this signaling pathw...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Morice, Sarah, Mullard, Mathilde, Brion, Regis, Dupuy, Maryne, Renault, Sarah, Tesfaye, Robel, Brounais-Le Royer, Bénédicte, Ory, Benjamin, Redini, Françoise, Verrecchia, Franck
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7766439/
https://ncbi.nlm.nih.gov/pubmed/33419295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123847
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak